Incubate bio
London
About Incubate bio
Incubate Bio specializes in computational biotechnology, focusing on early drug discovery. The company offers in silico data packages that include characterized and prioritized targets and biomarkers with critical evidence for outlicensing. Their platform, ALaSCA, is available to life sciences companies involved in drug discovery, medtech, bioactives research, and agri-tech. Additionally, Incubate Bio provides FlexWell incubation chambers for isolating specimens on slides.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Jan 2023)
- Website: incubate.bio
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Test and Measurement
Social Profiles
Canonical: https://fsome.com/organization/incubate-bio-2801368 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.